It has been observed that ART does not fully restore the polyfunctional, proliferative, or cytotoxic capabilities of dysfunctional HIV-specific CD8+ T cells and time from infection to ART treatment impacts the ability of ART to reduce exhaustion levels [64–66]. This evidence concerns the gene CD8A and infection.